Equities
  • Price (USD)39.54
  • Today's Change0.37 / 0.94%
  • Shares traded511.83k
  • 1 Year change-18.68%
  • Beta1.4982
Data delayed at least 15 minutes, as of Apr 23 2024 21:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cognex Corporation invents and commercializes technologies that address various critical manufacturing and distribution challenges. The Company is a global provider of machine vision products and solutions that improve efficiency and quality in businesses across industrial end markets. It operates through the machine vision technology segment. Its solutions blend physical products and software to capture and analyze visual information, allowing for the automation of manufacturing and distribution tasks for customers worldwide. Machine vision products are used to automate the manufacturing or distribution and tracking of discrete items, such as mobile phones, electric vehicle batteries and e-commerce packages, by locating, identifying, inspecting, and measuring them. Machine vision is important for applications in which human vision is inadequate to meet requirements for size, accuracy, or speed, or in instances where substantial cost savings or quality improvements are maintained.

  • Revenue in USD (TTM)837.55m
  • Net income in USD113.23m
  • Incorporated1981
  • Employees2.99k
  • Location
    Cognex CorpOne Vision DriveNATICK 01760United StatesUSA
  • Phone+1 (508) 650-3000
  • Fax+1 (508) 650-3333
  • Websitehttps://www.cognex.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CGNX:NSQ since
announced
Transaction
value
MORITEX CorpDeal completed29 Aug 202329 Aug 2023Deal completed-16.65%272.96m
Data delayed at least 15 minutes, as of Apr 23 2024 21:15 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Integra Lifesciences Holdings Corp1.54bn67.74m2.28bn3.95k34.321.4311.911.480.84440.844419.1920.310.40191.595.79390,667.301.773.331.923.6863.0963.674.397.992.187.950.48570.00-1.030.9219-62.482.19-2.97--
OSI Systems, Inc.1.37bn113.62m2.38bn6.24k21.193.0815.541.746.586.5879.2945.290.85652.183.95218,997.907.126.2311.639.1835.6135.698.317.070.79577.250.37230.008.043.25-20.4347.89-6.71--
Mirion Technologies Inc800.90m-96.90m2.50bn3.00k--1.6939.083.13-0.4993-0.49934.086.570.29353.093.62266,966.70-3.62---4.10--44.50---12.32--1.48-0.16910.3068--11.58--65.01------
Olink Holding AB (publ) - ADR169.60m-31.60m2.74bn707.00------16.15-0.2547-0.25471.36--0.31450.99632.94239,882.60-5.86---6.40--67.49---18.63--3.55--0.0506--21.27---145.90------
Badger Meter Inc740.77m102.31m5.32bn2.14k52.189.9440.447.183.473.4725.1318.221.083.078.39346,154.7014.8612.2618.1714.6039.2639.3813.8112.062.30--0.0036.3624.4010.1639.2527.226.7912.07
Vontier Corp3.10bn376.90m6.21bn8.00k16.636.9612.382.012.422.4219.845.770.71675.186.12386,900.008.7310.8011.1814.0446.2444.6212.1813.361.085.800.71942.24-2.803.03-6.08-0.50187.23--
Cognex Corp837.55m113.23m6.73bn2.99k60.034.4749.818.040.65250.65254.838.770.42131.666.67279,928.805.7010.636.2311.5671.7972.9713.5222.383.40--0.0057.03-16.750.7624-47.46-13.24-9.069.03
MKS Instruments Inc3.62bn-1.84bn7.36bn10.00k--2.97--2.03-27.56-27.5654.1736.950.35132.015.19362,100.00-17.86-1.60-19.57-1.7545.3544.95-50.84-3.252.011.160.6596--2.1111.78-652.85--6.692.44
Bio Rad Laboratories Inc2.67bn-637.32m9.42bn8.03k--0.9139--3.52-21.49-21.4991.24306.510.20711.655.43332,660.30-4.949.08-5.169.6053.5655.55-23.8641.974.340.30950.12070.00-4.673.1382.43--3.83--
Bruker Corp2.96bn427.20m11.34bn9.71k26.848.2320.953.832.912.9120.149.490.75421.646.15305,398.2010.858.3814.9911.4051.1749.8514.3911.390.994829.030.47569.8117.149.3644.0318.9116.794.56
Revvity Inc2.75bn179.50m12.45bn11.50k69.941.5820.364.531.445.5022.0363.790.19862.914.42239,180.101.304.761.455.3955.9857.196.5315.341.774.070.33136.52-16.95-0.1982-64.99-5.28-2.690.00
Avantor Inc6.97bn321.10m16.58bn14.50k51.593.1422.922.380.47310.473110.287.760.52715.295.88480,496.602.432.972.763.3533.9333.444.615.061.053.190.51320.00-7.263.51-51.52--31.17--
Data as of Apr 23 2024. Currency figures normalised to Cognex Corp's reporting currency: US Dollar USD

Institutional shareholders

43.08%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202317.09m9.95%
BlackRock Fund Advisorsas of 31 Dec 202313.81m8.04%
Walter Scott & Partners Ltd.as of 31 Dec 20238.71m5.07%
GIC Pte Ltd. (Investment Management)as of 05 Mar 20248.65m5.04%
T. Rowe Price Investment Management, Inc.as of 31 Dec 20235.58m3.25%
Brown Capital Management LLCas of 31 Dec 20235.42m3.15%
SSgA Funds Management, Inc.as of 31 Dec 20235.02m2.92%
Capital Research & Management Co. (Global Investors)as of 31 Dec 20233.55m2.07%
Geode Capital Management LLCas of 31 Dec 20233.19m1.86%
AllianceBernstein LPas of 31 Dec 20233.00m1.75%
More ▼
Data from 31 Dec 2023 - 15 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.